Bangalore, Feb 28(UNI) The city based Superspeciality Eye Hospital, Nethradhama has introduced, iLasik, an unique and revolutionery eye care technology, using Iiris recognition technology, to provide safe and accurate correction for refractive errors.
Speaking to newsmen Dr Sri Ganesh, who is also MD of the hospital said the Hospital had acquired the Visx and Intalase Lasik, one of the first centers to do so in the country, and succesfully conducted over 400 surgeries during last two months.
Informing that the iLasik was a high precision and safe technique for correction of Refractive errors, Dr Ganesh said that using latest technology correction of short sight could be done from minus one to minus 12 and long sight upto plus six and cylinder upto six Diaptors.
He said that the iLasik comes with the combined Infralase blade free technology and customVue Wavefront correction to provide an ultra safe and ultra precise correction for refractive errors due to its high safety profile and precision. "While the blood less and painless process of surgery using latest technology last for only 15 to 20 seconds the entire profile last for only for 15 minutes," Dr Ganesh said.
Emphasising the importance of the new technology Dr Ganesh informed that it was the only procedure which has been approved by U.S defense and NASA for Pilots and Astronauts. The patients who have crossed 18 years of age and above can avail this procedure to correct their refractive errors which offers permanent a solutions, he said.
He said iLasik technology which comes with the combined iris recognition technology with customised solution also offer a lot to law enforcement agencies in combating espionae and terrorism, Eye is unique for each individual as is the finger prints, he added.
He said among all the branches of medicine only Opthamology is the one which had witnessed the maximum advancement in the past two decades and future holds promising world for the blinds. Develooping artificial retina and bionic eye using stemcell transplant technology have offered breakthrough results.
UNI MV RS RKN1622